Yulu Qianxing Biotech Co-Hosts Successful 2022 World Medical Technology Summit and Wins VB-Find Award Top 100 Innovation

December 15, 2022, Beijing, China; Suzhou, China——The 2022 World Medical Technology Summit (December 14–15, 2022, Suzhou, China), co-hosted by Yulu Qianxing Biotechnology, has successfully concluded.

At the conference, Dr. Kenneth Merz, the company’s Chief Scientific Advisor, delivered a presentation titled “Computational Chemistry in the Limit is an 'Exact Science'”, providing an in-depth analysis of the technical mechanisms underlying molecular dynamics-assisted novel drug design.Dr. Liu Hao, CSO of Yulu Qianxing, delivered a keynote roadshow presentation titled “A New Drug Molecule Discovery Factory Driven by Dynamics + AI.”Dr. Zheng Zheng, Founder and Chairman of Yu Lu Qian Xing, joined hands with collaborative partners from the small-molecule sector (Dr. Li Gong, Director of Medicinal Chemistry at Beijing Anshi Biopharma), the large-molecule sector (Ms. Meng Liping, COO of Crystal Cloud Ke Rui Si), and upstream computing power suppliers (Mr. Chen Feng from Suzhou Supercomputing Center) to discuss practical application scenarios in AI-driven drug discovery (AIDD), the value of dynamics in empowering pharmaceutical companies, common concerns among pharma companies regarding AIDD services, and future prospects for AIDD-assisted new drug design.

Furthermore, at this conference, Yulu Qianxing Biotechnology was honored as one of the Top 100 Most Innovative Healthcare Technology Products in the VB-FIND Awards 2022, an accolade selected and presented by VCBeat’s VB-100.